(19)
(11) EP 4 121 020 A1

(12)

(43) Date of publication:
25.01.2023 Bulletin 2023/04

(21) Application number: 21770620.9

(22) Date of filing: 19.03.2021
(51) International Patent Classification (IPC): 
A61K 31/05(2006.01)
A61K 36/185(2006.01)
 A61K 31/352(2006.01)
C07C 39/10(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 36/185; A61K 31/352; A61K 31/05; C07C 65/19; C07C 39/19; C07C 39/23; Y02P 20/141; A61K 31/192
 
C-Sets:
  1. A61K 31/192, A61K 2300/00;
  2. A61K 31/05, A61K 2300/00;
  3. A61K 31/352, A61K 2300/00;
(86) International application number:
PCT/US2021/023291
(87) International publication number:
WO 2021/188983 (23.09.2021 Gazette 2021/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 20.03.2020 US 202062992582 P

(71) Applicant: The Queen's Medical Center
Honolulu, Hawaii 96813 (US)

(72) Inventors:
  • PENNER, Reinhold
    Honolulu, Hawaii 96813 (US)
  • NEUPANE, Ram P.
    Honolulu, Hawaii 96813 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) CANNABINOID COMPOSITIONS